Aldeyra Therapeutics, Inc. (ALDX)
Across 9 earnings reports since May 06, 2021, Aldeyra Therapeutics, Inc. (ALDX) has a clear post-earnings pattern. It moves ±7.32% on average after reporting and finishes higher 88.9% of the time. Its largest post-earnings gain was +16.27% (Mar 17, 2022) and its largest decline was -5.12% (May 05, 2022). The next earnings report is predicted for 2026-08-05 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
9
Avg Abs. Movement
±7.32%
Positive %
88.9%
Negative %
11.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 04, 2023 | ☀ PRE | $10.35 | $10.46 | $10.39 | 734,100 | +2.06% | open_in_new |
| Mar 09, 2023 | ☀ PRE | $7.77 | $7.95 | $7.90 | 889,000 | +7.19% | open_in_new |
| Nov 10, 2022 | ☀ PRE | $5.25 | $5.57 | $5.50 | 675,800 | +6.18% | open_in_new |
| Aug 05, 2022 | ☀ PRE | $6.10 | $7.38 | $6.92 | 2,078,600 | +10.9% | open_in_new |
| May 05, 2022 | ☀ PRE | $3.06 | $3.06 | $2.78 | 1,006,900 | -5.12% | open_in_new |
| Mar 17, 2022 | ☀ PRE | $4.37 | $4.88 | $4.86 | 1,392,800 | +16.27% | open_in_new |
| Oct 28, 2021 | ☀ PRE | $8.25 | $9.09 | $9.00 | 854,600 | +9.22% | open_in_new |
| Aug 05, 2021 | ☀ PRE | $8.84 | $9.58 | $9.57 | 626,000 | +8.26% | open_in_new |
| May 06, 2021 | ☀ PRE | $11.72 | $12.15 | $12.05 | 1,473,300 | +0.67% | open_in_new |
Earnings Count
9
Total earnings in dataset
Avg Abs. Movement
±7.32%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260610 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260501 | open_in_new SEC.gov |
| ARS | 20260427 | open_in_new SEC.gov |
| DEFA14A | 20260427 | open_in_new SEC.gov |
| DEF 14A | 20260427 | open_in_new SEC.gov |
| ARS | 20260427 | open_in_new SEC.gov |
| DEF 14A | 20260427 | open_in_new SEC.gov |
Frequently asked about ALDX earnings
When does Aldeyra Therapeutics, Inc. report earnings next? expand_more
Aldeyra Therapeutics, Inc. (ALDX)'s next earnings date is approximate for 2026-08-05. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ALDX stock move after earnings? expand_more
Over 9 reports, ALDX has moved an average of ±7.32% the session after earnings, closing higher 88.9% of the time.
What was ALDX's biggest post-earnings move? expand_more
ALDX's largest post-earnings gain on record was +16.27% on Mar 17, 2022, and its largest decline was -5.12% on May 05, 2022.
Where can I find Aldeyra Therapeutics, Inc.'s SEC filings? expand_more
All of Aldeyra Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right